Baseline characteristics of patients with STEMI treated with primary PCI who died or survived during a mean follow-up of 3.5 years
| Total cohort n=1313 | Survived during follow-up n=1132 | Died during follow-up n=181 | p Value | |
|---|---|---|---|---|
| Mean age | 62.3±13.1 | 60.8±12.2 | 72.3±13.0 | <0.0001 |
| Females | 296 (22.5%) | 241 (21.3%) | 55 (30.4%) | 0.0073 |
| Males | 1017 (77.5%) | 891 (78.7%) | 126 (69.6%) | |
| BMI* | 28.0 | 28.0±4.9 | 27.4±6.0 | 0.314 |
| Diabetes | 214 (16.3%) | 172 (15.2%) | 42 (23.3%) | 0.0084 |
| Hypertension | 564 (43.0%) | 476 (42.1%) | 88 (48.9%) | 0.086 |
| Smoker | 375 (28.6%) | 342 (30.2%) | 33 (18.3%) | 0.0007 |
| Ex-smoker | 258 (19.7%) | 229 (20.2%) | 29 (16.1%) | 0.187 |
| Hyperlipidaemia | 399 (30.4%) | 352 (31.1%) | 47 (26.1%) | 0.172 |
| Family history | 373 (28.4%) | 343 (30.3%) | 30 (16.7%) | <0.0001 |
| Prior PCI† | 121 (9.6%) | 93 (8.5%) | 28 (16.6%) | 0.002 |
| Prior CABG‡ | 43 (3.4%) | 34 (3.1%) | 9 (5.3%) | 0.169 |
*Body mass index.
†Percutaneous coronary intervention.
‡Coronary artery bypass grafting.
STEMI, ST-segment elevation myocardial infarction.